Drug
Cadisegliatin QD
Cadisegliatin QD: highest development phase Phase 2, developed by vTv Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- vTv Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cadisegliatin 800 mg QD NCT07616206 | Phase 2 | Type 1 Diabetes (T1D) |
Latest
No recent events.
Follow Cadisegliatin QD on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.